(PDF) An Abscopal Response to Radiation and Ipilimumab in a

An Abscopal Response to Radiation and Ipilimumab in a Patient With Metastatic Non-Small Cell Lung Cancer

Cancer immunology research - United States

doi 10.1158/2326-6066.cir-13-0115

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

October 9, 2013

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Unusual Cutaneous Reactions to Pemetrexed in a Patient With Metastatic Non-Small Cell Lung Cancer

Oncology, Gastroenterology and Hepatology Reports

English

Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient With Small-Cell Lung Cancer

Case Reports in Neurological Medicine

English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology

English

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients With Metastatic Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-17 Immune-Related Adverse Events in Patients With Metastatic Non-Small Cell Lung Cancer: Sex Differences and Response to Therapy

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.12-16 Significant Tumor Regression and Toxicity With Nivolumab Plus Ipilimumab in Small Cell Lung Cancer Patients Following Radiation

Journal of Thoracic Oncology

Respiratory Medicine

English

Second-Line Erlotinib in an EGFR Mutation-Negative Patient With Non-Small-Cell Lung Cancer

Current Oncology

English

Targeting Glutamine Metabolism to Improve Radiation Sensitivity in Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English